About Cinacalcet Hydrochloride API
Therapeutic CategoryEndocrinología
CAS Number
364782-34-3
API Technology
Sintética
Dose Form
Sólido oral/Tabletas
Dr Reddy's Development Status
Disponible
Available Regulatory Filing
USDMF, EUDMF, DMF de Canadá, DMF de Rusia, DMF de Brasil, DMF de China
Mechanism of Action
The calcium-sensing receptor on the surface of the chief cell of the parathyroid gland is the principal regulator of PTH synthesis and secretion. Cinacalcet, the active ingredient in Sensipar, directly lowers PTH levels by increasing the sensitivity of the calcium-sensing receptor to extracellular calcium. The reduction in PTH is associated with a concomitant decrease in serum calcium levels.
Indication
Sensipar is a calcium sensing receptor agonist indicated for:
- Secondary Hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis.
Limitations of use: Sensipar is not indicated for use in patients with CKD who are not on dialysis
- Hypercalcemia in adult patients with Parathyroid Carcinoma (PC)
- Hypercalcemia in adult patients with primary HPT for whom parathyroidectomy would be indicated on the basis of serum calcium levels, but who are unable to undergo parathyroidectomy
Related APIs
Clorhidrato De Cinacalcet
Endocrinología
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!